1-(Methoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95%, 5g

1,3-Dimethyl-1H-benzo[d]imidazol-3-ium iodide, 95.0%, 10g

(E)-ETHYL 3-(4-MORPHOLINOPHENYL)ACRYLATE, 95.0%, 100mg

10-[4-[4,6-Di(adamantan-1-yl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethyl-9,10-dihydroacridine (purified by sublimation)>99.0%(HPLC)200mg

(R)-2-Amino-5-(3,3-dimethylguanidino)pentanoic acid, 95+%, 1g

2-Chloropyridine-4-sulfonyl chloride, 98%, 250mg

Palmitoyl-glycine, 99.0%, 1g

2-Fluoro-4-nitrobenzonitrile, 97.0%, 1g

Colonne capillaire GC ROTI®Cap-1, 50 m, 0,32 mm, 1,00 µm, 1 pièce(s)

Pentadecan-1-ol, 95.0%, 500g

1-Cyclohexyl-1H-benzoimidazol-5-ylamine, 97%, 1g

Fmoc-L-azidoornithine, PEPTIPURE®, min.98%, pour la biochimie, 1 g, emballage en verre

2-Bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 97%, 100mg